We have determined lupus anticoagulants, anti-beta2 glycoprotein I (beta2GPI) and antiprothrombin antibodies in the Leiden Thrombophilia Study, a population-based case-control study designed to determine risk factors for deep venous thrombosis (DVT). Lupus anticoagulant (LAC) was measured in 473 patients and 472 control subjects. Four control subjects (0.9
作者：P G, de Groot；B, Lutters；R H W M, Derksen；T, Lisman；J C M, Meijers；F R, Rosendaal
来源：Journal of thrombosis and haemostasis : JTH 2005 年 3卷 9期
